Mercury Bio Revenue and Competitors
Employee Data
- Mercury Bio has 13 Employees.
- Mercury Bio grew their employee count by 0% last year.
Mercury Bio's People
| Name | Title | Email/Phone |
|---|
Mercury Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.5M | 29 | 7% | N/A | N/A |
#2 | $0.5M | 19 | 58% | $4.5M | N/A |
#3 | $3.4M | 22 | -29% | N/A | N/A |
#4 | $1.9M | 12 | 0% | N/A | N/A |
#5 | $5.3M | 34 | 6% | N/A | N/A |
#6 | $1.9M | 12 | -8% | N/A | N/A |
#7 | N/A | 13 | 0% | N/A | N/A |
#8 | $20.6M | 133 | 6% | N/A | N/A |
#9 | $1.1M | 7 | 0% | N/A | N/A |
#10 | $2175.6M | 14036 | 5% | N/A | N/A |
What Is Mercury Bio?
We want to shift the paradigm in drug delivery systems. \n\nMercury Bio has invented a drug delivery platform designed to unleash the potential of RNA and small-molecule drugs using reliable, cell-specific delivery—targeting only the cells that need therapy and working with the body to bypass immune reactions. \n\nNot only will our technology boost patient outcomes, it will help drug developers quicken products to market by reducing many of the obstacles, delays, and risks encountered by traditional drug delivery systems, spreading the viable reach of new medications in the process.\n\nBy advancing drug efficacy, lowering costs, reducing side effects, and shortening time to market, we aim to unlock the potential of new therapies and help make the world’s most advanced medicines more accessible to everyone.
keywords:N/A
N/A
Total Funding
13
Number of Employees
N/A
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Santa Fe
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 13 | -7% | N/A |
#2 | $0.7M | 13 | -38% | $1.3M |
#3 | $2.3M | 14 | -53% | N/A |
#4 | $0.8M | 14 | 8% | N/A |
#5 | $1.3M | 15 | N/A | N/A |